ivabradine has been researched along with Arrhythmias, Cardiac in 47 studies
*Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (19.15) | 29.6817 |
| 2010's | 27 (57.45) | 24.3611 |
| 2020's | 11 (23.40) | 2.80 |
| Authors | Studies |
|---|---|
| Hofmann, F; Ludwig, A; Stieber, J; Stöckl, G; Wieland, K | 1 |
| Bertero, A; Cain, K; Dupras, S; El-Nachef, D; Futakuchi-Tsuchida, A; Jayabalu, A; Kalucki, FA; Kattman, S; Knollmann, BC; MacLellan, WR; Marchianò, S; Murry, CE; Nakamura, DS; Nakamura, K; Neidig, LE; Pabon, L; Reinecke, H; Robinson, MR; Thies, RS; Tian, R; Tsuchida, H; Weber, GJ; Whittington, D; Yang, X | 1 |
| Depuydt, AS; Peigneur, S; Tytgat, J | 1 |
| Almorad, A; Bala, G; Beaver, TM; Brodt, CR; Brugada, P; Chierchia, GB; de Asmundis, C; Gauthey, A; La Meir, M; Lakkireddy, D; Lee, RJ; Monaco, C; Olshansky, B; Overeinder, I; Pannone, L; Sieira, J; Sorgente, A; Ströker, E | 1 |
| Penslar, J; Udupa, S | 1 |
| Gao, W; Guo, Y; Huang, M; Li, F; Liu, T; Xu, X | 1 |
| Ergul, Y; Gul, O; Kafali, HC | 1 |
| Çetin, T; Çınar, T; Çinier, G; Eren, S; Hayıroğlu, Mİ; Keskin, K; Pay, L; Tekkeşin, Aİ; Tezen, O; Yumurtaş, AÇ | 1 |
| Amstetter, D; Badt, F; Bittner, RE; Ebner, J; Hilber, K; Koenig, X; Rubi, L; Todt, H; Uhrin, P | 1 |
| Kruszewski, M; Leszek, P; Mackiewicz, U; Mączewski, M; Oknińska, M; Paterek, A; Śmigielski, W; Sochanowicz, B | 1 |
| Jæger, KH; Tveito, A; Wall, S | 1 |
| Mackiewicz, U; Mączewski, M; Marciszek, M; Oknińska, M; Paterek, A; Zambrowska, Z | 1 |
| Bisht, DS; Gokhroo, RK; Gupta, S; Kishore, K; Priti, K; Ranwa, BL | 1 |
| Çavuşoglu, Y; Mert, GÖ; Mert, KU; Morrad, B; Mutlu, F; Tahmazov, S | 1 |
| Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kaese, S; Kochhäuser, S; Lange, PS; Weller, J | 1 |
| Hancox, JC | 1 |
| Chobanyan-Jürgens, K; Duncker, D; Heusser, K; Jordan, J; Luft, FC; May, M; Mehling, H; Schröder, C; Tank, J; Veltmann, C | 1 |
| Mert, GÖ; Mert, KU; Şener, E | 1 |
| Ghadimi, N; Hosseinifard, H; Kaveh, S; Lijassi, A; Mehr, AZ; Shabaninejad, H | 1 |
| Lyon, AR; Ng, FS; Peters, NS; Shadi, IT | 1 |
| Arai, Y; Igata, S; Kinoshita, H; Kuwabara, Y; Kuwahara, K; Minami, T; Nakagawa, Y; Nakao, K; Nishikimi, T; Shibata, J; Takano, M; Ueshima, K; Usami, S; Yamada, C; Yamada, Y; Yasuno, S | 1 |
| Chu, S; Dobrzynski, H; Duda, M; Gerges, JY; Lewartowski, B; Mackiewicz, U; Mączewski, M | 1 |
| De Santis, V; Frati, G; Greco, E; Tritapepe, L | 1 |
| Alig, J; Bidaud, I; Dubel, S; Ehmke, H; Engeland, B; Eschenhagen, T; Fernandez, A; Isbrandt, D; Mangoni, ME; Marger, L; Marquilly, C; Mesirca, P; Miquerol, L; Müller, JC; Nargeot, J; Rollin, A; Seniuk, A; Singh, J; Torrente, AG; Vincent, A; Wickman, K | 1 |
| Caetano, J; Delgado Alves, J | 1 |
| Al-Kindi, SG; Oliveira, GH; Orasanu, G | 1 |
| Bellin, M; Chen, Z; Dorn, T; Dreizehnter, L; Goedel, A; Hinkel, R; Laugwitz, KL; Lipp, P; Moretti, A; Mummery, CL; Ng, JK; Pane, LS; Schneider, CM; Sinnecker, D; Tian, Q; Ward-van Oostwaard, D; Xian, W | 1 |
| Lancellotti, P | 1 |
| Ferrari, R; Ford, I; Fox, K; Robertson, M; Steg, PG; Tendera, M | 1 |
| Heusch, G | 1 |
| Akdemir, R; Balci, M; Dogan, M; Kara, E; Murat, SN; Orcan, S | 1 |
| Gardier, S; Pedretti, S; Raddatz, E; Sarre, A | 1 |
| DiMarco, JP; Mason, PK | 1 |
| DiFrancesco, D | 1 |
| D'Angelo, L; Fazio, G; Licata, P; Novo, G; Novo, S; Passantino, S; Sarulo, F; Spanò, C; Visconti, C; Zarcone, P | 1 |
| Bhargava, B; Parakh, N | 1 |
| Ferrari, R; Fox, KM | 1 |
| Baczkó, I; Bitay, M; Cerbai, E; Fülöp, F; Jaeger, K; Jost, N; Koncz, I; Kristóf, A; Orvos, P; Papp, JG; Szél, T; Tálosi, L; Varró, A; Virág, L | 1 |
| Fruhwald, F; Pieske, B | 1 |
| Böhm, M; Borer, JS; Ford, I; Komajda, M; O'Meara, E; Swedberg, K; Tardif, JC; Tavazzi, L | 1 |
| Böhm, M; Borer, JS; Chassany, O; Ekman, I; Ford, I; Komajda, M; Swedberg, K; Tavazzi, L | 1 |
| Clark, AL; Cleland, JG; Cullington, D; Goode, KM | 1 |
| Castagno, D; Claggett, B; McMurray, J; Petrie, MC | 1 |
| Drożdż, J; Filipiak, KJ; Grajek, S; Kasprzak, JD; Opolski, G; Rynkiewicz, A; Stępińska, J; Tykarski, A; Wożakowska Kapłon, B | 1 |
| Büter, I; Gams, E; Hohlfeld, T; Schipke, JD; Schmitz-Spanke, S | 1 |
| Menown, IB | 1 |
| Izzat, LM | 1 |
11 review(s) available for ivabradine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Review: HCN Channels in the Heart.
Topics: Arrhythmias, Cardiac; Cyclic Nucleotide-Gated Cation Channels; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Myocytes, Cardiac | 2022 |
Targeted Treatment of Inappropriate Sinoatrial Node Tachycardia Based on Electrophysiological and Structural Mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Heart Rate; Humans; Ivabradine; Sinoatrial Node; Tachycardia; Tachycardia, Sinus | 2022 |
Effect of ivabradine on cardiac arrhythmias: Antiarrhythmic or proarrhythmic?
Topics: Arrhythmias, Cardiac; Cardiovascular Agents; Heart Rate; Humans; Ivabradine | 2021 |
Comparative efficacy of ivabradine versus beta-blockers in patients with mitral stenosis in sinus rhythm: systematic review and meta-analysis.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Cardiovascular Agents; Heart Rate; Humans; Ivabradine; Mitral Valve Stenosis; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Heart rate and cardiovascular protection.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Atherosclerosis; Benzazepines; Cardiovascular Agents; Clinical Trials as Topic; Heart Failure; Heart Rate; Humans; Hypertension; Ivabradine; Myocardial Ischemia; Risk Factors | 2015 |
New pharmacological agents for arrhythmias.
Topics: Acetanilides; Adenosine A1 Receptor Agonists; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Benzofurans; Clinical Trials as Topic; Dronedarone; Humans; Ivabradine; Piperazines; Pyrrolidines; Ranolazine | 2009 |
Funny channel-based pacemaking.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Heart Conduction System; Heart Rate; Humans; Ion Channels; Ivabradine; Mutation | 2010 |
Rate control with ivabradine: angina pectoris and beyond.
Topics: Acute Coronary Syndrome; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Heart Failure; Heart Rate; Humans; Ivabradine | 2011 |
Heart rate: a forgotten link in coronary artery disease?
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Arteriosclerosis; Benzazepines; Coronary Artery Disease; Coronary Vessels; Disease Progression; Elasticity; Endothelium, Vascular; Heart Rate; Hemodynamics; Humans; Ivabradine; Myocardial Ischemia; Myocardium; Oxygen Consumption | 2011 |
[Selective I(f) channel inhibition: an alternative for treating coronary artery disease?].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Clonidine; Coronary Artery Disease; Humans; Isoindoles; Ivabradine; Phthalimides; Practice Guidelines as Topic; Practice Patterns, Physicians' | 2006 |
Ivabradine: a new strategy for management of stable angina.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Calcium Channel Blockers; Clinical Trials as Topic; Exercise Tolerance; Humans; Ivabradine; Treatment Outcome | 2007 |
6 trial(s) available for ivabradine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Ivabradine vs metoprolol in patients with acute inferior wall myocardial infarction-"Expanding arena for ivabradine".
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Atrioventricular Block; Benzazepines; Cardiotonic Agents; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Heart Block; Heart Failure; Humans; Inferior Wall Myocardial Infarction; Ivabradine; Male; Metoprolol; Middle Aged; Prospective Studies; Recurrence; Survival Analysis | 2017 |
Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Cardiovascular Agents; Cross-Over Studies; Double-Blind Method; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Muscle Proteins; Pacemaker, Artificial; Potassium Channels; Prospective Studies; Young Adult | 2018 |
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.
Topics: Adult; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Death, Sudden, Cardiac; Double-Blind Method; Female; Hospitalization; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Ventricular Dysfunction, Left; Young Adult | 2009 |
Arrhythmic effects of ivabradine in patients with coronary artery disease.
Topics: Adult; Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Coronary Angiography; Coronary Artery Disease; Female; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2009 |
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Double-Blind Method; Echocardiography; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Cause of Death; Chronic Disease; Double-Blind Method; Female; Heart Failure, Systolic; Humans; Ivabradine; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2011 |
30 other study(ies) available for ivabradine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Bradycardic and proarrhythmic properties of sinus node inhibitors.
Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Bradycardia; Cardiotonic Agents; Cloning, Molecular; Electrocardiography; Humans; Ivabradine; Mice; Mice, Inbred C57BL; Piperidines; Sinoatrial Node; Up-Regulation | 2006 |
Pharmacologic therapy for engraftment arrhythmia induced by transplantation of human cardiomyocytes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Cell- and Tissue-Based Therapy; Disease Models, Animal; Drug Combinations; Humans; Ivabradine; Male; Myocardial Infarction; Myocytes, Cardiac; Pluripotent Stem Cells; Stem Cell Transplantation; Swine; Tachycardia | 2021 |
Ivabradine in the Management of Pediatric Arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiovascular Agents; Child; Heart Rate; Humans; Ivabradine | 2023 |
Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Child; Female; Humans; Ivabradine; Stroke Volume; Tachycardia; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2023 |
Successful treatment of the focal ectopic atrial tachycardia in an infant with a single dose of ivabradin.
Topics: Arrhythmias, Cardiac; Catheter Ablation; Electrocardiography; Humans; Infant; Ivabradine; Male; Tachycardia, Ectopic Atrial; Tachycardia, Supraventricular | 2023 |
Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction.
Topics: Arrhythmias, Cardiac; Heart Failure; Humans; Ivabradine; Retrospective Studies; Stroke Volume; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2023 |
The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrioventricular Node; Cardiac Pacing, Artificial; Disease Models, Animal; Electrocardiography; Female; Heart Rate; Ivabradine; Mice, Inbred C57BL; Time Factors | 2021 |
Ivabradine prevents deleterious effects of dopamine therapy in heart failure: No role for HCN4 overexpression.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dopamine; Female; Heart Failure; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Muscle Proteins; Myocardium; Potassium Channels; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2021 |
Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes.
Topics: Action Potentials; Adult; Ajmaline; Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Computational Biology; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Heart Conduction System; Heart Defects, Congenital; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ivabradine; Mexiletine; Models, Cardiovascular; Mutation; Myocytes, Cardiac; Quinidine; Translational Research, Biomedical | 2021 |
Effects of ivabradine and beta-blocker therapy on dobutamine-induced ventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Dobutamine; Electrocardiography, Ambulatory; Female; Humans; Ivabradine; Male; Middle Aged | 2017 |
Antiarrhythmic properties of ivabradine in an experimental model of Short-QT- Syndrome.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Ivabradine; Refractory Period, Electrophysiological; Ventricular Dysfunction | 2017 |
Could ivabradine be a new treatment for the short QT syndrome?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Humans; Ivabradine; Models, Theoretical | 2017 |
Beneficial effects of ivabradine in atrial or ventricular arrhythmias.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Humans; Ivabradine; Tachycardia, Ectopic Junctional | 2018 |
Selective heart rate reduction with ivabradine slows ischaemia-induced electrophysiological changes and reduces ischaemia-reperfusion-induced ventricular arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Heart Rate; Ivabradine; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 2013 |
Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts.
Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Cations; Heart Failure; Heart Ventricles; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Mice; Mice, Transgenic | 2013 |
Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Calcium; Gene Expression Regulation; Ivabradine; Male; Myocardial Infarction; Potassium Channels; Rats; Rats, Inbred WKY | 2014 |
Ivabradine: a preliminary observation for a new terapeutic role in patients with multiple organ dysfunction syndrome.
Topics: Aged; Arrhythmias, Cardiac; Benzazepines; Cardiovascular Agents; Humans; Ivabradine; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Sepsis; Treatment Outcome | 2014 |
Cardiac arrhythmia induced by genetic silencing of 'funny' (f) channels is rescued by GIRK4 inactivation.
Topics: Animals; Arrhythmias, Cardiac; Benzazepines; Calcium Signaling; Disease Models, Animal; Female; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Heart Rate; Humans; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Ivabradine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Proteins; Myocytes, Cardiac; Oocytes; Patch-Clamp Techniques; Potassium Channels; Pregnancy; Xenopus | 2014 |
Ivabradine in Management of Heart Failure: a Critical Appraisal.
Topics: Arrhythmias, Cardiac; Benzazepines; Cardiomyopathies; Cardiovascular Agents; Clinical Studies as Topic; Heart Failure; Heart Rate; Heart Transplantation; Humans; Ivabradine; Shock, Cardiogenic; Ultrasonography | 2016 |
Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.
Topics: Action Potentials; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Case-Control Studies; Cisapride; Drug Evaluation; Humans; Induced Pluripotent Stem Cells; Ivabradine; Long QT Syndrome; Luminescent Proteins; Models, Cardiovascular; Myocytes, Cardiac; Potassium Channel Blockers; Voltage-Sensitive Dye Imaging | 2017 |
[Ivabradine (Procoralan)].
Topics: Arrhythmias, Cardiac; Benzazepines; Exercise; Heart Rate; Humans; Ischemia; Ivabradine | 2008 |
A BEAUTIFUL lesson--ivabradine protects from ischaemia, but not from heart failure: through heart rate reduction or more?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Coronary Artery Disease; Heart Failure; Humans; Ivabradine; Myocardial Ischemia; Retrospective Studies; Ventricular Dysfunction, Left | 2009 |
Specific inhibition of HCN channels slows rhythm differently in atria, ventricle and outflow tract and stabilizes conduction in the anoxic-reoxygenated embryonic heart model.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Biological Clocks; Blotting, Western; Chick Embryo; Cyclic Nucleotide-Gated Cation Channels; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Excitation Contraction Coupling; Heart; Heart Atria; Heart Conduction System; Heart Rate; Heart Ventricles; Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels; Hypoxia; Ivabradine; Myocardial Contraction; Oxygen; Potassium Channels; Time Factors; Tissue Culture Techniques | 2010 |
Ivabradine versus bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Bisoprolol; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2010 |
Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Dogs; Dose-Response Relationship, Drug; Electrophysiological Phenomena; Heart; Humans; Ivabradine; Kinetics; Potassium; Rabbits; Sodium Channel Blockers | 2011 |
Left ventricular remodelling in systolic heart failure using ivabradine. Slower is smaller is better?
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Female; Heart Failure; Humans; Ivabradine; Male; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Limited role for ivabradine in the treatment of chronic heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Chronic Disease; Female; Heart Failure; Humans; Ivabradine; Male; Middle Aged; Patient Selection; Stroke Volume; Ventricular Dysfunction, Left | 2011 |
Should we SHIFT our thinking about digoxin? Observations on ivabradine and heart rate reduction in heart failure.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Female; Heart Failure; Humans; Ivabradine; Kaplan-Meier Estimate; Male; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2012 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Diltiazem; Heart Diseases; Heart Rate; Humans; Hypertension; Ivabradine; Verapamil | 2012 |
The role of heart rate reduction in angina management and beyond.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Cardiotonic Agents; Heart Rate; Humans; Ivabradine; Risk Factors | 2008 |